Sibylle Loibl
0000-0001-6488-4958
Publication & Citation Trends
Publications
1,487 total
Alpelisib for <i>PIK3CA</i> -Mutated, Hormone Receptor–Positive Advanced Breast Cancer PDF
Cited by 2,514
OpenAlex
"Hidden Catholics","faith-blind" donors and "FBO empires" : a mixed-methods study on donor engagement of faith-based organisations in the Cameroonian health systema mixed-methods study on donor engagement of faith-based organisations in the Cameroonian health system
Cited by 2
Semantic Scholar
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Cited by 2,080
OpenAlex
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis PDF
Cited by 4,623
OpenAlex
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 PDF
Cited by 3,088
OpenAlex
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 PDF
Cited by 3,689
OpenAlex
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Cited by 2,647
OpenAlex
Plasma levels of scFv(FRP5)-ETA at steady state
Cited by 0
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(623)
HER2/EGFR in Cancer Research
(427)
Cancer Treatment and Pharmacology
(357)
Advanced Breast Cancer Therapies
(340)
Cancer Genomics and Diagnostics
(192)
Affiliations
Université Paris-Sud
Northwestern University
Ontario Institute for Cancer Research
Goethe University Frankfurt
Roche (Switzerland)